Dosing Frequency for Fluticasone/Vilanterol (Relvar Ellipta)
Fluticasone propionate/vilanterol (Relvar Ellipta) is administered once daily.
Dosing Schedule
The medication should be taken once daily at the same time each day 1. This once-daily dosing regimen applies to all approved formulations and indications, including:
- COPD patients: Fluticasone furoate/vilanterol administered once daily in clinical trials ranging from 12 weeks to 52 weeks 1
- Asthma patients: Once-daily administration demonstrated in trials up to 52 weeks 1
Clinical Evidence Supporting Once-Daily Dosing
The once-daily regimen has been extensively validated:
- Multiple studies confirm that once-daily FF/VI provides effective asthma control comparable to twice-daily ICS/LABA combinations 2, 3
- In pediatric populations (ages 5-17 years), once-daily dosing significantly improved lung function parameters 4
- The 24-hour duration of action allows for consistent bronchodilation and anti-inflammatory effects with single daily administration 5
Key Clinical Considerations
Timing consistency is critical: While the medication is taken once daily, patients should use it at approximately the same time each day to maintain steady therapeutic levels. The long-acting nature of vilanterol (LABA) and fluticasone furoate (ICS) provides 24-hour coverage with this single daily dose.
Common pitfall: Do not confuse this with twice-daily ICS/LABA combinations like fluticasone propionate/salmeterol, which require twice-daily administration. The furoate formulation of fluticasone combined with vilanterol specifically allows for once-daily dosing 2, 3.